Clinical CPD topic
Benign prostatic hyperplasia: practise, reflect and record
Practise benign prostatic hyperplasia through five clinical cases, review the explanations and build a professional learning record. Select immediate catheterisation and alpha-blocker treatment before a trial without catheter in acute urinary retention.
First published · Sources checked
What you’ll work on
- Select immediate catheterisation and alpha-blocker treatment before a trial without catheter in acute urinary retention.
- Choose finasteride escalation for persistent voiding symptoms with an enlarged prostate.
- Recognise antimuscarinic urinary retention and counsel on tamsulosin-related dizziness.
Think through a clinical case
Decide how you would approach this case before opening the question session.
A 78-year-old man is admitted with confusion. His daughter reports he has been increasingly drowsy over the past 48 hours and has not passed urine for 12 hours. He has a history of benign prostatic hyperplasia (BPH). On examination, his bladder is palpable suprapubically. What is the most appropriate immediate management?
A case from the UKMLA question bank. The session provides the answer and explanation after your attempt.
From a decision to a learning record
- Test your reasoning. Answer five questions from this topic’s clinical-content library.
- Explore the gaps. Review explanations and use Tutor to work through decisions that need more thought.
- Reflect on application. Describe what you learned and what you would change or investigate.
- Review your evidence. Confirm the activity and time spent, then retain or export your professional record.
Primary sources and further reading
Read the source in the same jurisdiction as your question session.
- Recommendations | Lower urinary tract symptoms in men: management | Guidance | NICEUK source
- Proscar 5mg film-coated Tablets — UK SmPCUK source
- Tamsulosin hydrochloride SUN Pharma 400 micrograms prolonged-release hard capsules — UK SmPCUK source
- Amitriptyline Hydrochloride 50mg/5ml Oral Solution — UK SmPCUK source
- Mirabegron Astellas 25mg & 50mg prolonged-release tablets — UK SmPCUK source